Skip to content

Debt-to-assets at other companies

Gilead Sciences logo
Gilead SciencesGILD
0.4×0.0×
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
0.3×0.0×
Arrowhead Research logo
Arrowhead ResearchARWR
0.0×
LQD
Liquidia CorporationLQDA
0.0×
Alkermes logo
AlkermesALKS
0.4×+0.3×
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
0.2×+0.1×

Other financials

Income statement

See full
Revenue$159.9M+43.3%
Operating income-$789.5M-5,100%
Net income-$790.2M-5,284%
EPS (diluted)-$13.43-4,377%

Balance sheet

See full
Cash & equivalents$261.5M+43.5%
Total debt$13.5M+56.4%
Total equity$242.5M+4.0%
Total assets$890.9M+29.1%

Cash flow

See full
Operating cash flow-$228.8M-11,566%
CapEx$664.0K+1,520%
Free cash flow-$229.4M-11,360%

Valuation

See full
Market cap$6.53B+152%
Enterprise value$6.28B+162%
P/S11.5×+4.6×

Profitability

See full
Operating margin-139.8%-168pp
Net margin-140.2%-169pp
FCF margin-30.3%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.1×-1.1×

Where this comes from

Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s debt-to-assets?
Mirum Pharmaceuticals, Inc. (MIRM) reported debt-to-assets of 0× in Q1 2026.
How has Mirum Pharmaceuticals, Inc.'s debt-to-assets changed year-over-year?
Mirum Pharmaceuticals, Inc.'s debt-to-assets increased by 21.6% year-over-year, from 0× to 0×.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s debt-to-assets?
Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s debt-to-assets has grown at a -3.2% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.